1. Teva Buys Allergan for $40.5 Billion

    Teva Buys Allergan for $40.5 Billion

    UPDATE: Israel’s Teva Pharmaceutical Industries Ltd. said in a statement Monday that it has agreed to acquire Dublin-based Allergan PLC’s generic pharmaceuticals business for $40.5 billion. Teva’s statement added that the acquisition will provide its customers with affordable quality medicine and benefit Teva’s stockholders...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. The acquisition of Naurex is a great fit for Allergan and a compelling and exciting investment. We expect Naurex will enhance Allergan's mental health portfolio and build on our strategy to lead in an important therapeutic area.
  3. Topics Mentioned